These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1690277)

  • 21. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant properties of montanide CSA 720 with a recombinant HIV P17 gag protein and synthetic peptide antigens.
    Kirkley JE; Goldstein AL; Naylor PH
    Scand J Immunol; 1996 Apr; 43(4):431-8. PubMed ID: 8668923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
    Ota A; Liu X; Fujio H; Sakato N; Ueda S
    Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antibody response to the HIV-1 specific "out" (vpu) protein: identification of an immunodominant epitope and correlation of antibody detectability to clinical stages.
    Schneider T; Hildebrandt P; Rönspeck W; Weigelt W; Pauli G
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):943-50. PubMed ID: 1697179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
    Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
    Kageyama S; Katsumoto T; Taniguchi K; Ismail SI; Shimmen T; Sasao F; Gao M; Owatari S; Wakamiya N; Tsuchie H; Ueda S; Shiraki K; Kurimura T
    Acta Virol; 1996 Sep; 40(4):195-200. PubMed ID: 9014009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slight difference in primary amino acid sequence of p17 matrix protein of HIV-1 exerts profound influence on its antigenicity.
    Taniguchi K; Tsuchie H; Kageyama S; Iwasaki M; Takagi T; Sasao F; Ueda S; Kurimura T
    Arch Virol; 1998; 143(5):881-90. PubMed ID: 9645195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-P30-52 monoclonal antibody cross-reacted to Env V3 and inhibited the viral multiplication of HIV-1-infected MT-4 cells.
    Ota A; Bautista AN; Yadav ML; Ueda S
    Hybridoma; 1999 Apr; 18(2):139-47. PubMed ID: 10380013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network.
    Viscidi R; Ellerbeck E; Garrison L; Midthun K; Clements ML; Clayman B; Fernie B; Smith G
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1251-6. PubMed ID: 1706607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag.
    de Goede AL; Boers PH; Dekker LJ; Osterhaus AD; Gruters RA; Rimmelzwaan GF
    Vaccine; 2009 Sep; 27(42):5735-9. PubMed ID: 19647812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysine oligopeptide method for human immunodeficiency virus infection.
    Okuda K; Kaneko T; Yamakawa T; Tanaka S; Shigematsu T; Yamamoto A; Hamajima K; Nakajima K; Kawamoto S; Phanuphak P
    J Mol Recognit; 1993 Sep; 6(3):101-9. PubMed ID: 8060667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal analysis of murine B cell response to the human immunodeficiency virus type 1 (HIV1)-gag p17 and p25 antigens.
    Robert-Hebmann V; Emiliani S; Jean F; Resnicoff M; Traincard F; Devaux C
    Mol Immunol; 1992 Jun; 29(6):729-38. PubMed ID: 1376412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping.
    Papsidero LD; Sheu M; Ruscetti FW
    J Virol; 1989 Jan; 63(1):267-72. PubMed ID: 2462060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-HIV-1 p17 antibody as anti-HIV agent].
    Tsuchie H; Tochikura A; Kageyama S; Kurimura T
    Nihon Rinsho; 1993 Sep; 51 Suppl():213-8. PubMed ID: 8271386
    [No Abstract]   [Full Text] [Related]  

  • 38. Candidate multi-epitope vaccines in aluminium adjuvant induce high levels of antibodies with predefined multi-epitope specificity against HIV-1.
    Ding J; Lu Y; Chen Y
    FEMS Immunol Med Microbiol; 2000 Oct; 29(2):123-7. PubMed ID: 11024351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Map of sequential B cell epitopes of the HIV-1 transmembrane protein using human antibodies as probe.
    Goudsmit J; Meloen RH; Brasseur R
    Intervirology; 1990; 31(6):327-38. PubMed ID: 1704000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
    Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.